Dinaciclib is a novel potent small molecule inhibitor of cyclin-dependent kinases (CDK)1, CDK2, CDK5, and CDK9. Patients with relapsed multiple myeloma and 5 prior lines of therapy, with measurable disease, were enrolled.
For research use only. We do not sell to patients.
| Name | Dinaciclib(SCH-727965) |
|---|---|
| Iupac Chemical Name | (S)-3-(((3-Ethyl-5-(2-(2-hydroxyethyl)piperidin-1-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide |
| Synonyms | SCH727965 |
| Molecular Formula | C21H28N6O2 |
| Molecular Weight | 396.49 |
| Smile | C(C)C=1C=NN2C1N=C(C=C2NCC=2C=[N+](C=CC2)[O-])N2[C@@H](CCCC2)CCO |
| InChiKey | PIMQWRZWLQKKBJ-SFHVURJKSA-N |
| InChi | InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1 |
| CAS Number | 779353-01-4 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | crystalline solid |
|---|---|
| Purity | >98% by HPLC |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |